Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
"Traded poorly"
Down 3% on turnover of only 2.5m shares ain't even trading just sodding mm's p.....g about again.
What boring little lives they must lead.
Crude. No one is buying Sareum (or they shouldn't be) based on earnings and fundamentals. You are buying a piece of their IP and what the potential value of that may be. Personally, I happen to think SAR will be worth anything between £0 and £2 billion pre commercialisation and multiples of that once we get to market. I also believe won't get as far as commercialisation but that's my opinion. It is educated gambling as Thoth calls it. Let the SP do what it does until the news starts to flow.
NEAR STARS which is where this SP will be
Earnings announcement are rarely good days for companies like SAR. Retail investor build up expectations but there is seldom any material news in the earnings reports. Looks at Avacta, ODX, GDR etc all traded poorly on earnings and trading updates.
IMHO - the gap between the results and conference may well be strategic. I predicted a couple of weeks back that the CTA announcement should come before the end of October if there is a chance of getting approval before Christmas so as to start in the New Year.
I believe, they will wrap up the results and then in short order confirm CTA is in before the investor meet. For sure, the HNWI’s will be wanting SAR to stick with the declared time line.
GLA
STREAN SAR is an anagram of TRANS ARSE
Strean, within 7 minutes you posted two comments expressing the same thing i.e. no news for 3 weeks, "back to watching paint dry". I actually think the next two weeks will be very revealing. But it's your veiled attempt to sow doubt which I find a bit pathetic. You're dealing with a bulletin board full of LTHs with extremely sticky fingers. We've seen people like you come and go, usually just before significant news. But you think we'll all sell up just because you predict the SP will fall and because there will be no news for 3 weeks? That's why I said you're barking and that's why I think you're wrong.
Strean - whilst i agree the MMs will pull this back for a few days whilst collecting shares for the inevitable rise, i cannot agree with your statement of no news for 3 weeks ... the November 2nd presentation will spell out our future and should be IMHO a major catalyst for a SP rise ... and i personally expect that rise to start the middle of next week in anticipation of what might be said or what extra RNS's are released ... its our time and we are all prepared to wait a few more weeks
I expect this to be over 10p come mid November based on what gets said and released around 2nd november
Strean - if you’re still sulking because you’ve lost half your investment (your words, 05 Oct) sell up and move on. And don’t buy in with so little knowledge. Not an insult, genuine advice.
If you genuinely knew about Sareum and the pipeline when you allegedly bought in, and got spiked, you wouldn’t be stressing and you’d be a bit more patient.
Either that, or you have another reason for being so down in this genuine once in a lifetime opportunity.
Nice try though.
Strean - You seem quite concerned with paint drying, are you invested in Dulux too? Pharma is a slow burn process. If you want daily tweets and an RNS per week then perhaps SAR isn't for you.
Strean, you're barking up the wrong tree old boy!
Daniel, we don't have a Lenigas on the BOD for no. 3 to happen, these chaps are sincere.
Also we are likely to get info. on releasing shareholder value which they have done insofar but without doubt plenty more to come.
Like most here who have been invested over the years at sub 1p and especially those who last March saw 0.0025p, I can assure you we are well pleased with where we are and what we have insofar given the circumstances and evident manipulation.
It's just results.
The presentation will be because of one of three factors;
1) SAR now have more professional backers so need to behave more professionally in presenting results
2) SAR have good news to share that they want to share with the world
3) SAR have bad news to share that they wish to polish with a presentation
My money is on 1 or 2. Leaning towards 1. But don't dismiss 3...
Steve196 - Results means exactly what it says on the tin - RESULTS - don’t expect any early fireworks !! Hopefully NEWS will follow RESULTS fairly quickly, patience is a virtue.
There may be other RNS in the next couple of weeks and i believe that the next solid SP baseline will be around the latest warrants price. So be prepared to be on double digit. GLA
I believe there must be a further RNS to come before the presentation in order to allow certain responses to obvious questions.
There is a s also a reiteration that Sareum aims to produce value through licensing. So multiple licences may be the commercial route forward.
All good
This is indeed great news, only a fool would make a company investor presentation in to a negative.
A strategic presentation of what has been achieved to date, our financial standing , the functional strategy to implement the future of SAR and the size and direction of the carrots in regard to developments.
Very pleased and this all forms part of the busy 2 months....excellent soap box communication opportunity.